Brian M. Gallagher Jr. bought ALRN once, on Jul 5, 2017

Gallagher Brian M. Jr. is a biotech investor, entrepreneur, and corporate director with extensive experience in financing and building life sciences companies.( He has served as a director of Aileron Therapeutics Inc. (ALRN), where he was a reporting corporate insider on SEC Form 4 filings, reflecting his role in the company’s governance and investment activities.( In addition to Aileron, he has held board and director roles at multiple biopharmaceutical companies, including Translate Bio Inc., Rein Therapeutics Inc., and eFFECTOR Therapeutics Inc., emphasizing his focus on early- and growth-stage therapeutics enterprises.(

Gallagher’s broader career includes leadership and advisory positions across the biotech ecosystem, encompassing venture investing, board service, and corporate advisory work.( His association with numerous SEC Form D filings as an executive officer for more than a dozen companies further underscores his prominence in life sciences financing and company formation.( Gallagher holds a Ph.D. and M.S. in Organic Chemistry from the University of Michigan and a B.S. in Chemistry from the University of Massachusetts Amherst, providing a strong scientific foundation for his investment and board work in biotechnology.(

Written by Perplexity from public sources.